• 1
    Arroyo V, Colmenero J. Ascites and hepato-renal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003; 38 (Suppl 1): S6989.
  • 2
    Magan AA, Khalil AA, Ahmed MH. Terlipressin and hepato-renal syndrome: what is important for nephrologists and hepatologists. World J Gastroenterol 2010; 16: 513947.
  • 3
    Wong F, Nadim MK, Kellum JA, et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 60: 7029.
  • 4
    Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepato-renal syndrome in cirrhosis. Gut 2007; 56: 13108.
  • 5
    Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 4039.
  • 6
    Mazur JE, Cooper TB, Dasta JF. Terlipressin in hepato-renal syndrome. Ann Pharmacother 2011; 45: 3807.
  • 7
    Gerbes AL, Huber E, Gulberg V. Terlipressin for hepato-renal syndrome: continuous infusion as an alternative to iv bolus administration. Gastroenterology 2009; 137: 117981.
  • 8
    Boyer TD, Sanyal AJ, Garcia-Tsao G, et al. Predictors of response to terlipressin plus albumin in hepato-renal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol 2010. doi: DOI: 10/1016/j.jhep.2010.11.020.
  • 9
    Triantos CK, Samonakis D, Thalheimer U, et al. Terlipressin therapy for renal failure in cirrhosis. Eur J Gastroenterol Hepatol 2010; 22: 4816.
  • 10
    Mitzner SR, Stange J, Klammt S, et al. Improvement of hepato-renal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 27786.
  • 11
    Rifai K, Kribben A, Gerken G, Haag S. Extracorporeal liver support by fractionated plasma separation and absorption (Prometheus®) in patients with acute-on-chronic liver failure (HELIOS study): a prospective randomized controlled multicenter study. J Hepatol 2010; 52 (Suppl. 1): S3.